Stock comparison
Merck & Co., Inc. is 196.5x more valuable than Stoke Therapeutics, Inc. by market capitalization ($366.20 B vs $1.86 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Merck & Co., Inc. is 196.5x more valuable than Stoke Therapeutics, Inc. by market capitalization ($366.20 B vs $1.86 B).
Market value leader
MRK
Merck & Co., Inc. is 196.5x more valuable than Stoke Therapeutics, Inc. by market capitalization ($366.20 B vs $1.86 B).
Revenue leader
MRK
STOK: $184.42M vs MRK: $65.01B.
Profit leader
MRK
STOK: -$6.88M vs MRK: $18.25B.
Margin leader
MRK
STOK: -3.7% vs MRK: 28.1% net margin.
| Metric | STOK | MRK |
|---|---|---|
| Market cap | $1.86 B | $366.20 B |
| US-listed rank | #2183 | #35 |
| Revenue (latest FY) | $184.42M | $65.01B |
| Net income (latest FY) | -$6.88M | $18.25B |
| Net margin | -3.7% | 28.1% |
| P/E (trailing FY) | - | 20.1x |
| SEC filings | 586 | 998 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Merck & Co., Inc. is 196.5x more valuable than Stoke Therapeutics, Inc. by market capitalization ($366.20 B vs $1.86 B).
In their latest fiscal years, Stoke Therapeutics, Inc. reported $184.42M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Stoke Therapeutics, Inc. and Merck & Co., Inc., or browse the full rankings.